Respiratory News and Research

RSS

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.

15 Dec 2023

Hospitalized influenza patients can also suffer long-term, negative health effects

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus's ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling health problems known as long COVID.

14 Dec 2023

Hidden reservoir revealed: Extracellular vesicles could be potential source of COVID recurrence

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has posed unprecedented challenges worldwide.

14 Dec 2023

Rift over when to use N95s puts health workers at risk again

Three years after more than 3,600 health workers died of covid-19, occupational safety experts warn that those on the front lines may once again be at risk if the Centers for Disease Control and Prevention takes its committee's advice on infection control guidelines in health care settings, including hospitals, nursing homes, and jails.

14 Dec 2023

IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows

The role of type-2 interferon (IFNγ) in antiviral immunity.

14 Dec 2023

New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data

The risk factors associated with CAP caused by serotypes in the different pneumococcal vaccines.

14 Dec 2023

Study shows lasting COVID-19 symptoms lead to economic struggles for US families

Study reveals that persistent COVID-19 symptoms and severe infections significantly impact the economic conditions of US families, with low-income households being more vulnerable to financial hardships.

13 Dec 2023

COVID-19 vaccination eased anxiety, insomnia, and depression in Chinese adults, study finds

Study reveals that COVID-19 vaccination significantly reduces the prevalence of anxiety, insomnia, and depression symptoms among Chinese adults, with vaccinated individuals reporting lower severity of these conditions compared to non-vaccinated individuals.

13 Dec 2023

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

13 Dec 2023

Immunopeptidomics offer new hope in cancer research

In this new omg OMx podcast episode, Bruker's Kate Stumpo speaks to Nicola Ternette on the incredible world of immunopeptidomics - the implications they could have for research and how they help us understand the immune system better.

From Bruker Daltonics 13 Dec 2023

U.S. veterans' study reveals key insights into Long COVID and protective role of vaccination

Study examines the clinical characteristics and trends of post-COVID-19 condition (PCC) in U.S. veterans, showing the protective effect of vaccination and the need for precise symptom documentation for effective research and clinical care.

12 Dec 2023

RBD-focused vaccines may offer broader protection against emerging COVID-19 variants

Published in The Lancet's eBioMedicine, 76 healthy adults from Melbourne, aged 18 to 64 who were previously vaccinated with licensed SARS-CoV-2 vaccines, were randomized to receive a fourth dose of a novel protein vaccine, mRNA vaccine or placebo.

12 Dec 2023

Evaluating the health risks associated with dietary exposure to metals

The problem of foodborne metal contamination has taken on new urgency, thanks in part to a 2021 US Congressional Report detailing high levels of metals found in infant food pulled off grocery shelves.

12 Dec 2023

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants

Five DNA vaccine candidates based on different SARS-CoV-2 strains.

12 Dec 2023

Study identifies key factor in lung and eye damage in preemies

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing.

11 Dec 2023

New SARS-CoV-2 variant JN.1 shows increased transmissibility and immune resistance

A Japanese study published in BioRxiv explores the virological characteristics of the SARS-CoV-2 JN.1 variant, finding it has a higher effective reproductive number and stronger resistance to immunity from other variants, potentially due to the L455S spike protein mutation.

11 Dec 2023

COVID-19 significantly raises risk of severe complications in pregnant women

Study found that pregnant mothers with COVID-19 face a significantly higher risk of severe maternal morbidity (SMM), including adult respiratory distress syndrome and acute renal failure, emphasizing the urgent need for their early diagnosis and treatment.

10 Dec 2023

Study links air pollution to increased risks of preterm birth and low birth weight

Study highlights the importance of reducing air pollution exposure during pregnancy to prevent risks like preterm birth and low birth weight, showing a strong correlation between air quality and maternal and neonatal health outcomes.

10 Dec 2023

Repeated mRNA vaccines supercharge immune response against COVID-19, study finds

Study published in Nature Immunology reveals that repeated mRNA COVID-19 vaccinations enhance immune response, especially in previously infected individuals, leading to a diversified and increased number of immune cell clones and a stronger ability to combat various virus strains.

7 Dec 2023

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Respiratory News and Research

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Hospitalized influenza patients can also suffer long-term, negative health effects

Hidden reservoir revealed: Extracellular vesicles could be potential source of COVID recurrence

Rift over when to use N95s puts health workers at risk again

IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows

New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data

Study shows lasting COVID-19 symptoms lead to economic struggles for US families

COVID-19 vaccination eased anxiety, insomnia, and depression in Chinese adults, study finds

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

Immunopeptidomics offer new hope in cancer research

U.S. veterans' study reveals key insights into Long COVID and protective role of vaccination

RBD-focused vaccines may offer broader protection against emerging COVID-19 variants

Evaluating the health risks associated with dietary exposure to metals

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants

Study identifies key factor in lung and eye damage in preemies

New SARS-CoV-2 variant JN.1 shows increased transmissibility and immune resistance

COVID-19 significantly raises risk of severe complications in pregnant women

Study links air pollution to increased risks of preterm birth and low birth weight

Repeated mRNA vaccines supercharge immune response against COVID-19, study finds

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News